Catechins in dietary supplements and hepatotoxicity

Digestive Diseases and Sciences

Volumn 58, Issue 9, 2013, Pages 2682-2690

  Navarro, Victor J ^a   Bonkovsky, Herbert L ^b   Hwang, Sun Il ^b   Vega, Maricruz ^a   Barnhart, Huiman ^c   Serrano, Jose ^d  

^a EINSTEIN MEDICAL CENTER   (United States)

^b CAROLINAS MEDICAL CENTER   (United States)

^c DUKE UNIVERSITY MEDICAL CENTER   (United States)

^d NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES   (United States)

Author keywords

Contamination; EGCG; Green tea extract; Hepatocellular jaundice; Hepatotoxin

Indexed keywords

CATECHIN; GREEN TEA EXTRACT;

ADULT; ARTICLE; CHINESE HERB; CLINICAL ARTICLE; CONCENTRATION (PARAMETERS); DIET SUPPLEMENTATION; DISEASE SEVERITY; FEMALE; HUMAN; INTERNATIONAL NORMALIZED RATIO; LIVER INJURY; LIVER TOXICITY; MALE; PRIORITY JOURNAL; WEIGHT REDUCTION;

ADULT; CATECHIN; DIETARY SUPPLEMENTS; DRUG-INDUCED LIVER INJURY; FEMALE; HUMANS; MALE; MIDDLE AGED; PLANT PREPARATIONS; YOUNG ADULT;

EID: 84884207529     PISSN: 01632116     EISSN: 15732568     Source Type: Journal    
DOI: 10.1007/s10620-013-2687-9     Document Type: Article

References (29)

1. Qato DM, Alexander GC, Conti RM, Johnson M, Schumm P, Lindau ST. Use of prescription and over-the-counter medications and dietary supplements among older adults in the United States. JAMA. 2008;300:2867-2878.
2. US Food and Drug Administration. Dietary Supplements. Aug 2005. Available at http://www.fda.gov/food/dietarysupplements/default.htm. Accessed September 1, 2011.
3. Cole MR, Fetrow CW. Adulteration of dietary supplements. Am J Health Syst Pharm. 2003;60:1576-1580.
4. Adachi M, Saito H, Kobayashi H, et al. Hepatic injury in 12 patients taking the herbal weight loss aids Chaso or Onshido. Ann Intern Med. 2003;139:488-492.
5. Graham HN. Green tea composition, consumption, and polyphenol chemistry. Prev Med. 1992;21:334-350.
6. Isbrucker RA, Bausch J, Edwards JA, Wolz E. Safety studies on epigallocatechingallate (EGCG) preparations. Part 1: genotoxicity. Food Chem Toxicol. 2006;44:626-635.
7. Isbrucker RA, Edwards JA, Wolz E, Davidovich A, Bausch J. Safety studies on epigallocatechingallate (EGCG) preparations. Part 2: dermal, acute and short-term toxicity studies. Food Chem Toxicol. 2006;44:636-650.
8. Isbrucker RA, Edwards JA, Wolz E, Davidovich A, Bausch J. Safety studies on epigallocatechingallate (EGCG) preparations. Part 3: teratogenicity and reproductive toxicity studies in rats. Food Chem Toxicol. 2006;44:651-661.
9. Galati G, Lin A, Sultan AM, O'Brien PJ. Cellular and in vivo hepatotoxicity caused by green tea phenolic acids and catechins. Free Radic Biol Med. 2006;40:570-580.
10. Takami S, Imai T, Hasumura M, Cho YM, Onose J, Hirose M. Evaluation of toxicity of green tea catechins with 90-day dietary administration to F344 rats. Food Chem Toxicol. 2008;46:2224-2229.
11. Ullmann U, Haller J, Decourt JP, Girault N, Girault J, Richard-Caudron AS. A single ascending dose study of epigallocatechingallate in healthy volunteers. J Int Med Res. 2003;31:88-101.
12. Pisters KM, Newman RA, Coldman B, et al. Phase I trial of oral green tea extract in adult patients with solid tumors. J Clin Oncol. 2001;19:1830-1838.
13. Gloro R, Hourmand-Ollivier I, Mosquet B, et al. Fulminant hepatitis during self-medication with hydroalcoholic extract of green tea. Eur J Gastroenterol Hepatol. 2005;17:1135-1137.
14. Jimenez-Saenz M, Martinez-Sanchez MC. Acute hepatitis associated with the use of green tea infusions. J Hepatol. 2006;44:616-617.
15. Bonkovsky HL. Hepatotoxicity associated with supplements containing Chinese green tea (Camellia sinensis). Ann Intern Med. 2006;144:68-71.
16. Molinari M, Watt KD, Kruszyna T, et al. Acute liver failure induced by green tea extracts: case report and review of the literature. Liver Transpl. 2006;12:1892-1895.
17. Javaid A, Bonkovsky HL. Hepatotoxicity due to extracts of Chinese green tea (Camellia sinensis): a growing concern. J Hepatol. 2006;45:334-335.
18. Chalasani N, et al. Causes, clinical features, and outcomes from a prospective study of drug induced liver injury in the United States. Gastroenterology. 2008;135:1924-1934.
19. Fontana RJ, Watkins PB, Bonkovsky HL, et al. Drug-induced liver injury network (DILIN) prospective study: rationale, design and conduct. Drug Saf. 2009;32:55-68.
20. Vega M, Vuppalanchi R, Bonkovsky H, et al. The US drug induced liver injury network: establishment of an herbal and dietary supplements (HDS) repository. Hepatology. 2011;54:528A (Abstract 341).
21. Hwang SI, Lee YY, Park JO, et al. Effects of a single dose of oral iron on hepcidin concentrations in human urine and serum analyzed by a robust LC-MS/MS method. Clin Chim Acta. 2011;412:2241-2247.
22. US Food and Drug Administration. Warning on Hydroxycut Products. May 1, 2009. Available at http://www.fda.gov/ForConsumers/ConsumerUpdates/ucm152152. htm. Accessed September 1, 2011.
23. Seddick M, Lucidarme D, Creusy C, Filoche B. Is exolise hepatotoxic? Gastroenterol Clin Biol. 2001;25:834-835.
24. Sarma DN, Barrett ML, Chavez ML, et al. Safety of green tea extracts: a systematic review by the US Pharmacopeia. Drug Saf. 2008;31:469-484.
25. Lambert JD, Kennett MJ, Sang S, Reuhl KR, Ju J, Yang CS. Hepatotoxicity of high oral dose (-)-epigallocatechin-3-gallate in mice. Food Chem Toxicol. 2010;48:409-416.
26. Brown JC, Jiang X. Prevalence of antibiotic-resistant bacteria in herbal products. J Food Prot. 2008;71:1486-1490.
27. Stickel F, Droz S, Patsenker E, Bogli-Stuber K, Aebi B, Leib SL. Severe hepatotoxicity following ingestion of Herbalife nutritional supplements contaminated with Bacillus subtilis. J Hepatol. 2009;50:111-117.
28. Demeule M, Michaud-Levesque J, Annabi B, et al. Green tea catechin as novel antitumor and antiangiogenic. Curr Med Chem-Anti-Cancer Agents. 2002;2:441-463.
29. Ciesek S, von Hahn T, Colpitts CC, et al. The green tea polyphenol, epigallocatechin-3-gallate, inhibits hepatitis C virus entry. Hepatology. 2011;54:1947-1955.